A cross-sectional study comparing the expression of DNA repair molecules in subjects with and without atherosclerotic plaques
Background Atherosclerosis, serving as the primary pathological mechanism at the core of cardiovascular disease, is now widely acknowledged to be associated with DNA damage and repair, contributing to atherosclerotic plaque formation. Therefore, molecules involved in the DNA repair process may play...
Saved in:
| Published in | Molecular biology reports Vol. 51; no. 1; p. 953 |
|---|---|
| Main Authors | , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Dordrecht
Springer Netherlands
01.12.2024
Springer Nature B.V |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Background
Atherosclerosis, serving as the primary pathological mechanism at the core of cardiovascular disease, is now widely acknowledged to be associated with DNA damage and repair, contributing to atherosclerotic plaque formation. Therefore, molecules involved in the DNA repair process may play an important role in the progression of atherosclerosis. Our research endeavors to explore the contributions of specific and interrelated molecules involved in DNA repair (
APE1
,
BRCA1
,
ERCC2
,
miR-221-3p
,
miR-145-5p
, and
miR-155-5p
) to the development of atherosclerotic plaque and their interactions with each other.
Methods & results
Gene expression study was conducted using the real-time polymerase chain reaction (qRT-PCR) method on samples from carotid artery atherosclerotic plaques and nonatherosclerotic internal mammary arteries obtained from 50 patients diagnosed with coronary artery disease and carotid artery disease. Additionally, 50 healthy controls were included for the determination of 8-hydroxy-2’-deoxyguanosine (8-OHdG). Although no difference was observed in mRNA gene expressions, we noted a decrease in
miR-155-5p
gene expression (
p
= 0.003) and an increase in
miR-221-3p
gene expression (
p
= 0.015) in plaque samples, while
miR-145-5p
gene expression remained unchanged (
p
= 0.57). Regarding serum 8-OHdG levels, patients exhibited significantly higher levels (1111.82 ± 28.64) compared to controls (636.23 ± 24.23) (
p
< 0.0001).
Conclusions
In our study demonstrating the role of miR-155-5p and miR-221-3p in atherosclerosis, we propose that these molecules are potential biomarkers and therapeutic targets for coronary artery diseases and carotid artery disease. |
|---|---|
| AbstractList | BackgroundAtherosclerosis, serving as the primary pathological mechanism at the core of cardiovascular disease, is now widely acknowledged to be associated with DNA damage and repair, contributing to atherosclerotic plaque formation. Therefore, molecules involved in the DNA repair process may play an important role in the progression of atherosclerosis. Our research endeavors to explore the contributions of specific and interrelated molecules involved in DNA repair (APE1, BRCA1, ERCC2, miR-221-3p, miR-145-5p, and miR-155-5p) to the development of atherosclerotic plaque and their interactions with each other.Methods & resultsGene expression study was conducted using the real-time polymerase chain reaction (qRT-PCR) method on samples from carotid artery atherosclerotic plaques and nonatherosclerotic internal mammary arteries obtained from 50 patients diagnosed with coronary artery disease and carotid artery disease. Additionally, 50 healthy controls were included for the determination of 8-hydroxy-2’-deoxyguanosine (8-OHdG). Although no difference was observed in mRNA gene expressions, we noted a decrease in miR-155-5p gene expression (p = 0.003) and an increase in miR-221-3p gene expression (p = 0.015) in plaque samples, while miR-145-5p gene expression remained unchanged (p = 0.57). Regarding serum 8-OHdG levels, patients exhibited significantly higher levels (1111.82 ± 28.64) compared to controls (636.23 ± 24.23) (p < 0.0001).ConclusionsIn our study demonstrating the role of miR-155-5p and miR-221-3p in atherosclerosis, we propose that these molecules are potential biomarkers and therapeutic targets for coronary artery diseases and carotid artery disease. Atherosclerosis, serving as the primary pathological mechanism at the core of cardiovascular disease, is now widely acknowledged to be associated with DNA damage and repair, contributing to atherosclerotic plaque formation. Therefore, molecules involved in the DNA repair process may play an important role in the progression of atherosclerosis. Our research endeavors to explore the contributions of specific and interrelated molecules involved in DNA repair (APE1, BRCA1, ERCC2, miR-221-3p, miR-145-5p, and miR-155-5p) to the development of atherosclerotic plaque and their interactions with each other. Gene expression study was conducted using the real-time polymerase chain reaction (qRT-PCR) method on samples from carotid artery atherosclerotic plaques and nonatherosclerotic internal mammary arteries obtained from 50 patients diagnosed with coronary artery disease and carotid artery disease. Additionally, 50 healthy controls were included for the determination of 8-hydroxy-2'-deoxyguanosine (8-OHdG). Although no difference was observed in mRNA gene expressions, we noted a decrease in miR-155-5p gene expression (p = 0.003) and an increase in miR-221-3p gene expression (p = 0.015) in plaque samples, while miR-145-5p gene expression remained unchanged (p = 0.57). Regarding serum 8-OHdG levels, patients exhibited significantly higher levels (1111.82 ± 28.64) compared to controls (636.23 ± 24.23) (p < 0.0001). In our study demonstrating the role of miR-155-5p and miR-221-3p in atherosclerosis, we propose that these molecules are potential biomarkers and therapeutic targets for coronary artery diseases and carotid artery disease. Background Atherosclerosis, serving as the primary pathological mechanism at the core of cardiovascular disease, is now widely acknowledged to be associated with DNA damage and repair, contributing to atherosclerotic plaque formation. Therefore, molecules involved in the DNA repair process may play an important role in the progression of atherosclerosis. Our research endeavors to explore the contributions of specific and interrelated molecules involved in DNA repair ( APE1 , BRCA1 , ERCC2 , miR-221-3p , miR-145-5p , and miR-155-5p ) to the development of atherosclerotic plaque and their interactions with each other. Methods & results Gene expression study was conducted using the real-time polymerase chain reaction (qRT-PCR) method on samples from carotid artery atherosclerotic plaques and nonatherosclerotic internal mammary arteries obtained from 50 patients diagnosed with coronary artery disease and carotid artery disease. Additionally, 50 healthy controls were included for the determination of 8-hydroxy-2’-deoxyguanosine (8-OHdG). Although no difference was observed in mRNA gene expressions, we noted a decrease in miR-155-5p gene expression ( p = 0.003) and an increase in miR-221-3p gene expression ( p = 0.015) in plaque samples, while miR-145-5p gene expression remained unchanged ( p = 0.57). Regarding serum 8-OHdG levels, patients exhibited significantly higher levels (1111.82 ± 28.64) compared to controls (636.23 ± 24.23) ( p < 0.0001). Conclusions In our study demonstrating the role of miR-155-5p and miR-221-3p in atherosclerosis, we propose that these molecules are potential biomarkers and therapeutic targets for coronary artery diseases and carotid artery disease. Atherosclerosis, serving as the primary pathological mechanism at the core of cardiovascular disease, is now widely acknowledged to be associated with DNA damage and repair, contributing to atherosclerotic plaque formation. Therefore, molecules involved in the DNA repair process may play an important role in the progression of atherosclerosis. Our research endeavors to explore the contributions of specific and interrelated molecules involved in DNA repair (APE1, BRCA1, ERCC2, miR-221-3p, miR-145-5p, and miR-155-5p) to the development of atherosclerotic plaque and their interactions with each other.BACKGROUNDAtherosclerosis, serving as the primary pathological mechanism at the core of cardiovascular disease, is now widely acknowledged to be associated with DNA damage and repair, contributing to atherosclerotic plaque formation. Therefore, molecules involved in the DNA repair process may play an important role in the progression of atherosclerosis. Our research endeavors to explore the contributions of specific and interrelated molecules involved in DNA repair (APE1, BRCA1, ERCC2, miR-221-3p, miR-145-5p, and miR-155-5p) to the development of atherosclerotic plaque and their interactions with each other.Gene expression study was conducted using the real-time polymerase chain reaction (qRT-PCR) method on samples from carotid artery atherosclerotic plaques and nonatherosclerotic internal mammary arteries obtained from 50 patients diagnosed with coronary artery disease and carotid artery disease. Additionally, 50 healthy controls were included for the determination of 8-hydroxy-2'-deoxyguanosine (8-OHdG). Although no difference was observed in mRNA gene expressions, we noted a decrease in miR-155-5p gene expression (p = 0.003) and an increase in miR-221-3p gene expression (p = 0.015) in plaque samples, while miR-145-5p gene expression remained unchanged (p = 0.57). Regarding serum 8-OHdG levels, patients exhibited significantly higher levels (1111.82 ± 28.64) compared to controls (636.23 ± 24.23) (p < 0.0001).METHODS & RESULTSGene expression study was conducted using the real-time polymerase chain reaction (qRT-PCR) method on samples from carotid artery atherosclerotic plaques and nonatherosclerotic internal mammary arteries obtained from 50 patients diagnosed with coronary artery disease and carotid artery disease. Additionally, 50 healthy controls were included for the determination of 8-hydroxy-2'-deoxyguanosine (8-OHdG). Although no difference was observed in mRNA gene expressions, we noted a decrease in miR-155-5p gene expression (p = 0.003) and an increase in miR-221-3p gene expression (p = 0.015) in plaque samples, while miR-145-5p gene expression remained unchanged (p = 0.57). Regarding serum 8-OHdG levels, patients exhibited significantly higher levels (1111.82 ± 28.64) compared to controls (636.23 ± 24.23) (p < 0.0001).In our study demonstrating the role of miR-155-5p and miR-221-3p in atherosclerosis, we propose that these molecules are potential biomarkers and therapeutic targets for coronary artery diseases and carotid artery disease.CONCLUSIONSIn our study demonstrating the role of miR-155-5p and miR-221-3p in atherosclerosis, we propose that these molecules are potential biomarkers and therapeutic targets for coronary artery diseases and carotid artery disease. BACKGROUND: Atherosclerosis, serving as the primary pathological mechanism at the core of cardiovascular disease, is now widely acknowledged to be associated with DNA damage and repair, contributing to atherosclerotic plaque formation. Therefore, molecules involved in the DNA repair process may play an important role in the progression of atherosclerosis. Our research endeavors to explore the contributions of specific and interrelated molecules involved in DNA repair (APE1, BRCA1, ERCC2, miR-221-3p, miR-145-5p, and miR-155-5p) to the development of atherosclerotic plaque and their interactions with each other. METHODS & RESULTS: Gene expression study was conducted using the real-time polymerase chain reaction (qRT-PCR) method on samples from carotid artery atherosclerotic plaques and nonatherosclerotic internal mammary arteries obtained from 50 patients diagnosed with coronary artery disease and carotid artery disease. Additionally, 50 healthy controls were included for the determination of 8-hydroxy-2’-deoxyguanosine (8-OHdG). Although no difference was observed in mRNA gene expressions, we noted a decrease in miR-155-5p gene expression (p = 0.003) and an increase in miR-221-3p gene expression (p = 0.015) in plaque samples, while miR-145-5p gene expression remained unchanged (p = 0.57). Regarding serum 8-OHdG levels, patients exhibited significantly higher levels (1111.82 ± 28.64) compared to controls (636.23 ± 24.23) (p < 0.0001). CONCLUSIONS: In our study demonstrating the role of miR-155-5p and miR-221-3p in atherosclerosis, we propose that these molecules are potential biomarkers and therapeutic targets for coronary artery diseases and carotid artery disease. |
| ArticleNumber | 953 |
| Author | Guven, Mehmet Arapi, Berk Malikova, Narmina Unal, Selin Omeroglu, Suat Nail |
| Author_xml | – sequence: 1 givenname: Berk surname: Arapi fullname: Arapi, Berk organization: Department of Cardiovascular Surgery Cerrahpasa School of Medicine, Istanbul University-Cerrahpasa – sequence: 2 givenname: Selin surname: Unal fullname: Unal, Selin organization: Department of Medical Biology, Cerrahpasa Medicine Faculty, Istanbul University-Cerrahpasa – sequence: 3 givenname: Narmina surname: Malikova fullname: Malikova, Narmina organization: Department of Medical Biology, Cerrahpasa Medicine Faculty, Istanbul University-Cerrahpasa – sequence: 4 givenname: Suat Nail surname: Omeroglu fullname: Omeroglu, Suat Nail organization: Department of Cardiovascular Surgery Cerrahpasa School of Medicine, Istanbul University-Cerrahpasa – sequence: 5 givenname: Mehmet surname: Guven fullname: Guven, Mehmet email: mguven@iuc.edu.tr organization: Department of Medical Biology, Cerrahpasa Medicine Faculty, Istanbul University-Cerrahpasa |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/39230767$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNkc1u1DAUhS1URKeFF2CBLLFhE7j29e9yVH6lqt2UdeRxHJpREgc7UemCd8czKSCxQN3YXnzn3Ct_Z-RkjGMg5CWDtwxAv8uMAWIFXFRgjVGVeUI2TGqshNXmhGwAgVXCSHZKznLeA4BgWj4jp2g5glZ6Q35uqU8x5yoHP3dxdD3N89LcUx-HyaVu_Ebn20DDjymFnAtAY0vfX21pCpPrEh1iH_zSh0y7keZlty81md518y11Y3N8xGWmrpSUMb4v59x5OvXu-xLyc_K0dX0OLx7uc_L144ebi8_V5fWnLxfby8qjtHMluRHKqbZsvEOuHLIGhdlZDkpbwZ0JprENa5VyLWc8YOOls9Lo1uuWe8Rz8mbtnVI8zJ3rocs-9L0bQ1xyjUyi1gjAH4ECSCVBHNDX_6D7uKTyhSulmUC0hXr1QC27ITT1lLrBpfv6t4MC8BU4ikih_YMwqA899Sq6LqLro-jalBCuoTwdJIX0d_Z_Ur8A_euquA |
| Cites_doi | 10.1016/j.critrevonc.2014.01.008 10.1038/ncomms1601 10.1111/jcmm.12358 10.1158/1541-7786.MCR-15-0399 10.4070/kcj.2015.45.5.364 10.1016/j.biopha.2017.04.106 10.1016/j.toxlet.2018.04.028 10.1161/ATVBAHA 10.6026/97320630013017 10.1002/glia.23988 10.1007/s12038-021-00235-6 10.1016/j.dnarep.2015.03.002 10.1371/journal.pone.0046551 10.1159/000478071 10.1016/j.ijcard.2022.05.039 10.1155/2015/354517 10.3390/ijms241814186 10.3390/ijms24109021 10.1155/2015/531740 10.12659/MSM.909614 10.1001/jamaneurol.2020.2658 10.1016/j.exger.2011.10.004 10.1161/STROKEAHA.115.010567 10.3390/ijms242417613 10.1016/j.atherosclerosis.2015.06.031 10.1080/1354750X 10.1016/j.hlc.2013.05.651 10.3390/ijms25084351 10.12659/MSM.910986 10.1016/j.actbio.2018.04.036 10.3390/ncrna8040047 10.1146/annurev-physiol-021115-105127 10.3390/diagnostics10110875 10.1038/ncb1909 10.1186/s12872-017-0596-0 10.1186/s41021-019-0119-6 10.1038/s41598-017-03434-0 10.1371/journal.pone.0074466 10.1016/j.yjmcc.2015.07.005 10.3389/fphar.2019.00463 10.1073/pnas.0914143107 10.1517/14728222.2013.745512 10.3389/fphys.2019.00123 10.1161/CIRCRESAHA 10.3390/ijms131216929 10.3390/jcm8122199 10.3978/j.issn.2225-319X.2013.07.06 10.1016/j.cpcardiol.2019.04.001 10.1016/j.clinbiochem.2022 10.1016/j.jtcvs.2012.12.064 10.1093/humupd/dmz043 10.1038/srep21789 10.3390/cells11091509 10.1038/nm.2459 10.1073/pnas.1002472107 10.3389/fcvm.2022.1040971 10.1161/CIRCRESAHA.107.152942 10.1089/gtmb.2023.0002 |
| ContentType | Journal Article |
| Copyright | The Author(s), under exclusive licence to Springer Nature B.V. 2024 Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. 2024. The Author(s), under exclusive licence to Springer Nature B.V. Copyright Springer Nature B.V. Dec 2024 |
| Copyright_xml | – notice: The Author(s), under exclusive licence to Springer Nature B.V. 2024 Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. – notice: 2024. The Author(s), under exclusive licence to Springer Nature B.V. – notice: Copyright Springer Nature B.V. Dec 2024 |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7TK 7TM 8FD FR3 K9. P64 RC3 7X8 7S9 L.6 |
| DOI | 10.1007/s11033-024-09886-8 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Neurosciences Abstracts Nucleic Acids Abstracts Technology Research Database Engineering Research Database ProQuest Health & Medical Complete (Alumni) Biotechnology and BioEngineering Abstracts Genetics Abstracts MEDLINE - Academic AGRICOLA AGRICOLA - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Genetics Abstracts Technology Research Database Nucleic Acids Abstracts ProQuest Health & Medical Complete (Alumni) Engineering Research Database Neurosciences Abstracts Biotechnology and BioEngineering Abstracts MEDLINE - Academic AGRICOLA AGRICOLA - Academic |
| DatabaseTitleList | Genetics Abstracts MEDLINE MEDLINE - Academic AGRICOLA |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Chemistry Biology |
| EISSN | 1573-4978 |
| EndPage | 953 |
| ExternalDocumentID | 39230767 10_1007_s11033_024_09886_8 |
| Genre | Journal Article |
| GroupedDBID | --- -Y2 -~C .86 .GJ .VR 06C 06D 0R~ 0VY 123 1SB 203 28- 29M 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2P1 2VQ 2~H 30V 3SX 4.4 406 408 409 40E 53G 5QI 5RE 5VS 67N 67Z 6NX 78A 7X7 88E 88I 8AO 8FE 8FH 8FI 8FJ 8TC 8UJ 95- 95. 95~ 96X AAAVM AABHQ AACDK AAHBH AAHNG AAIAL AAJBT AAJKR AANXM AANZL AAPKM AARHV AARTL AASML AATNV AATVU AAUYE AAWCG AAYIU AAYQN AAYTO AAYZH ABAKF ABBBX ABBRH ABBXA ABDBE ABDZT ABECU ABFSG ABFTV ABHLI ABHQN ABJNI ABJOX ABKCH ABKTR ABMNI ABMQK ABNWP ABPLI ABQBU ABQSL ABRTQ ABSXP ABTEG ABTHY ABTKH ABTMW ABULA ABUWG ABWNU ABXPI ACAOD ACBXY ACDTI ACGFS ACGOD ACHSB ACHXU ACKNC ACMDZ ACMLO ACOKC ACOMO ACPIV ACPRK ACSTC ACZOJ ADBBV ADHHG ADHIR ADHKG ADIMF ADKNI ADKPE ADRFC ADTPH ADURQ ADYFF ADYPR ADZKW AEBTG AEFIE AEFQL AEGAL AEGNC AEJHL AEJRE AEKMD AEMSY AENEX AEOHA AEPYU AESKC AETLH AEVLU AEXYK AEZWR AFBBN AFDZB AFEXP AFGCZ AFHIU AFKRA AFLOW AFOHR AFQWF AFWTZ AFZKB AGAYW AGDGC AGGDS AGJBK AGMZJ AGQEE AGQMX AGQPQ AGRTI AGWIL AGWZB AGYKE AHAVH AHBYD AHMBA AHPBZ AHSBF AHWEU AHYZX AIAKS AIGIU AIIXL AILAN AITGF AIXLP AJBLW AJRNO AJZVZ AKMHD ALIPV ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMXSW AMYLF AMYQR AOCGG ARMRJ ASPBG ATHPR AVWKF AXYYD AYFIA AZFZN AZQEC B-. BA0 BBNVY BBWZM BDATZ BENPR BGNMA BHPHI BPHCQ BSONS BVXVI CAG CCPQU COF CS3 CSCUP DDRTE DL5 DNIVK DPUIP DU5 DWQXO EBD EBLON EBS EIOEI EJD EMOBN EN4 EPAXT ESBYG F5P FEDTE FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC FYUFA G-Y G-Z GGCAI GGRSB GJIRD GNUQQ GNWQR GQ7 GQ8 GXS H13 HCIFZ HF~ HG5 HG6 HMCUK HMJXF HQYDN HRMNR HVGLF HZ~ I09 IHE IJ- IKXTQ ITM IWAJR IXC IZIGR IZQ I~X I~Z J-C J0Z JBSCW JCJTX JZLTJ KDC KOV KOW KPH LAK LK8 LLZTM M1P M2P M4Y M7P MA- N2Q NB0 NDZJH NPVJJ NQJWS NU0 O9- O93 O9G O9I O9J OAM OVD P19 PF0 PHGZM PHGZT PJZUB PPXIY PQGLB PQQKQ PROAC PSQYO PT4 PT5 Q2X QOK QOR QOS R4E R89 R9I RHV RIG RNI RNS ROL RPX RRX RSV RZC RZE RZK S16 S1Z S26 S27 S28 S3A S3B SAP SBL SBY SCLPG SDH SDM SHX SISQX SJYHP SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SV3 SZN T13 T16 TEORI TSG TSK TSV TUC TUS U2A U9L UG4 UKHRP UOJIU UTJUX UZXMN VC2 VFIZW W23 W48 WH7 WJK WK6 WK8 YLTOR Z45 ZMTXR ZOVNA ZXP ~A9 ~EX ~KM AAYXX CITATION CGR CUY CVF ECM EIF NPM 7TK 7TM 8FD FR3 K9. P64 RC3 7X8 7S9 L.6 |
| ID | FETCH-LOGICAL-c359t-52846a6f767b326a31d348b92067942a8e8d9d1f66af212e3dc5a9587fc7f2c33 |
| IEDL.DBID | U2A |
| ISSN | 0301-4851 1573-4978 |
| IngestDate | Fri Aug 22 20:20:05 EDT 2025 Fri Jul 11 04:34:47 EDT 2025 Fri Jul 25 12:19:01 EDT 2025 Mon Jul 21 05:55:27 EDT 2025 Tue Jul 01 03:18:40 EDT 2025 Mon Jul 21 06:06:47 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | APE1 Atherosclerotic plaques ERCC2 miR-221-3p BRCA1 miR-155-5p miR-145-5p |
| Language | English |
| License | 2024. The Author(s), under exclusive licence to Springer Nature B.V. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c359t-52846a6f767b326a31d348b92067942a8e8d9d1f66af212e3dc5a9587fc7f2c33 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| PMID | 39230767 |
| PQID | 3100714339 |
| PQPubID | 54080 |
| PageCount | 1 |
| ParticipantIDs | proquest_miscellaneous_3153773002 proquest_miscellaneous_3100565042 proquest_journals_3100714339 pubmed_primary_39230767 crossref_primary_10_1007_s11033_024_09886_8 springer_journals_10_1007_s11033_024_09886_8 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2024-12-01 |
| PublicationDateYYYYMMDD | 2024-12-01 |
| PublicationDate_xml | – month: 12 year: 2024 text: 2024-12-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationPlace | Dordrecht |
| PublicationPlace_xml | – name: Dordrecht – name: Netherlands |
| PublicationSubtitle | An International Journal on Molecular and Cellular Biology |
| PublicationTitle | Molecular biology reports |
| PublicationTitleAbbrev | Mol Biol Rep |
| PublicationTitleAlternate | Mol Biol Rep |
| PublicationYear | 2024 |
| Publisher | Springer Netherlands Springer Nature B.V |
| Publisher_xml | – name: Springer Netherlands – name: Springer Nature B.V |
| References | D Gohil (9886_CR7) 2023; 24 JR Czochor (9886_CR21) 2016; 14 9886_CR46 N Valeri (9886_CR22) 2010; 107 J Kamtchum-Tatuene (9886_CR2) 2020; 77 SY Cui (9886_CR17) 2014; 18 N Al-Moghrabi (9886_CR24) 2023; 24 Y Lu (9886_CR28) 2018; 38 PC Shukla (9886_CR35) 2011; 2 MS Aloi (9886_CR32) 2021; 69 HA Bazan (9886_CR47) 2015; 46 A Uryga (9886_CR5) 2016; 78 M Mijit (9886_CR12) 2021; 2 SK Das (9886_CR14) 2010; 107 AR Teixeira (9886_CR10) 2022; 9 X Ma (9886_CR19) 2013; 22 J Zhu (9886_CR33) 2012; 7 Y Xue (9886_CR41) 2015; 241 AO Iusupova (9886_CR48) 2023; 24 EL Solly (9886_CR29) 2019; 8 KK Singh (9886_CR37) 2013; 146 9886_CR13 MS Sudhanva (9886_CR16) 2022; 11 R Fridlich (9886_CR36) 2015; 30 R Bruen (9886_CR20) 2019; 10 X Zhang (9886_CR54) 2022; 360 K Gray (9886_CR3) 2015; 116 SA Jin (9886_CR49) 2015; 45 D Santovito (9886_CR56) 2013; 17 S Wei (9886_CR18) 2018; 295 X Li (9886_CR31) 2016; 6 9886_CR50 T Cervelli (9886_CR4) 2012; 13 G Singh Istas (9886_CR40) 2017; 7 DA Chistiakov (9886_CR11) 2015; 2015 S Xue (9886_CR57) 2019; 10 S Alipour (9886_CR34) 2017; 91 K Liu (9886_CR53) 2017; 17 H Hameed (9886_CR62) 2016; 29 L Li (9886_CR15) 2018; 24 AN Rozhkov (9886_CR51) 2022; 8 F Otsuka (9886_CR25) 2013; 2 L Meng (9886_CR55) 2023; 111 9886_CR26 C Rippe (9886_CR43) 2012; 47 V Turan (9886_CR9) 2020; 26 9886_CR61 M Kusakabe (9886_CR8) 2019; 41 F Rodier (9886_CR59) 2009; 11 S Chang (9886_CR23) 2011; 17 P Telkoparan-Akillilar (9886_CR45) 2022; 47 AE Bildirici (9886_CR44) 2018; 23 AJ Patterson (9886_CR52) 2020; 10 G Dai (9886_CR42) 2007; 101 G Miceli (9886_CR1) 2024; 25 9886_CR6 Q Li (9886_CR60) 2018; 24 S Fichtlscherer (9886_CR27) 2010; 107 M Arts-de Jong (9886_CR38) 2014; 91 Z Yalım (9886_CR58) 2023; 27 R Krishnan (9886_CR30) 2017; 13 S Zhou (9886_CR39) 2021; 46 |
| References_xml | – volume: 91 start-page: 159 year: 2014 ident: 9886_CR38 publication-title: Crit Rev Oncol Hematol doi: 10.1016/j.critrevonc.2014.01.008 – ident: 9886_CR61 – volume: 2 start-page: 593 year: 2011 ident: 9886_CR35 publication-title: Nat Commun doi: 10.1038/ncomms1601 – volume: 18 start-page: 1913 year: 2014 ident: 9886_CR17 publication-title: J Cell Mol Med doi: 10.1111/jcmm.12358 – volume: 14 start-page: 363 year: 2016 ident: 9886_CR21 publication-title: Mol Cancer Res doi: 10.1158/1541-7786.MCR-15-0399 – volume: 45 start-page: 364 year: 2015 ident: 9886_CR49 publication-title: Korean Circ J doi: 10.4070/kcj.2015.45.5.364 – volume: 91 start-page: 526 year: 2017 ident: 9886_CR34 publication-title: Rev Biomed Pharmacother doi: 10.1016/j.biopha.2017.04.106 – volume: 295 start-page: 220 year: 2018 ident: 9886_CR18 publication-title: Toxicol Lett doi: 10.1016/j.toxlet.2018.04.028 – volume: 38 start-page: e159 year: 2018 ident: 9886_CR28 publication-title: Arterioscler Thromb Vasc Biol doi: 10.1161/ATVBAHA – volume: 13 start-page: 17 year: 2017 ident: 9886_CR30 publication-title: Bioinformation doi: 10.6026/97320630013017 – volume: 69 start-page: 1736 year: 2021 ident: 9886_CR32 publication-title: Glia doi: 10.1002/glia.23988 – volume: 47 start-page: 1 year: 2022 ident: 9886_CR45 publication-title: J Biosci doi: 10.1007/s12038-021-00235-6 – volume: 30 start-page: 11 year: 2015 ident: 9886_CR36 publication-title: DNA Repair (Amst) doi: 10.1016/j.dnarep.2015.03.002 – volume: 7 start-page: e46551 year: 2012 ident: 9886_CR33 publication-title: PLoS ONE doi: 10.1371/journal.pone.0046551 – ident: 9886_CR46 doi: 10.1159/000478071 – volume: 360 start-page: 68 year: 2022 ident: 9886_CR54 publication-title: Int J Cardiol doi: 10.1016/j.ijcard.2022.05.039 – volume: 2015 start-page: 354517 year: 2015 ident: 9886_CR11 publication-title: Biomed Res Int doi: 10.1155/2015/354517 – volume: 24 start-page: 14186 year: 2023 ident: 9886_CR7 publication-title: Int J Mol Sci doi: 10.3390/ijms241814186 – volume: 24 start-page: 9021 year: 2023 ident: 9886_CR24 publication-title: Int J Mol Sci doi: 10.3390/ijms24109021 – ident: 9886_CR50 doi: 10.1155/2015/531740 – volume: 24 start-page: 5951 year: 2018 ident: 9886_CR60 publication-title: Med Sci Monit doi: 10.12659/MSM.909614 – volume: 77 start-page: 1524 year: 2020 ident: 9886_CR2 publication-title: JAMA Neurol doi: 10.1001/jamaneurol.2020.2658 – volume: 47 start-page: 45 year: 2012 ident: 9886_CR43 publication-title: Exp Gerontol doi: 10.1016/j.exger.2011.10.004 – volume: 46 start-page: 3285 year: 2015 ident: 9886_CR47 publication-title: Stroke doi: 10.1161/STROKEAHA.115.010567 – volume: 24 start-page: 17613 year: 2023 ident: 9886_CR48 publication-title: Int J Mol Sci doi: 10.3390/ijms242417613 – volume: 241 start-page: 671 year: 2015 ident: 9886_CR41 publication-title: Atherosclerosis doi: 10.1016/j.atherosclerosis.2015.06.031 – volume: 23 start-page: 670 year: 2018 ident: 9886_CR44 publication-title: Biomarkers doi: 10.1080/1354750X – volume: 2 start-page: 151 year: 2021 ident: 9886_CR12 publication-title: J Cell Signal – volume: 22 start-page: 811 year: 2013 ident: 9886_CR19 publication-title: Heart Lung Circ doi: 10.1016/j.hlc.2013.05.651 – volume: 25 start-page: 4351 year: 2024 ident: 9886_CR1 publication-title: Int J Mol Sci doi: 10.3390/ijms25084351 – volume: 24 start-page: 4894 year: 2018 ident: 9886_CR15 publication-title: Med Sci Monit doi: 10.12659/MSM.910986 – ident: 9886_CR26 doi: 10.1016/j.actbio.2018.04.036 – volume: 8 start-page: 47 year: 2022 ident: 9886_CR51 publication-title: Noncoding RNA doi: 10.3390/ncrna8040047 – volume: 78 start-page: 45 year: 2016 ident: 9886_CR5 publication-title: Annu Rev Physiol doi: 10.1146/annurev-physiol-021115-105127 – volume: 10 start-page: 875 year: 2020 ident: 9886_CR52 publication-title: Diagnostics (Basel) doi: 10.3390/diagnostics10110875 – volume: 11 start-page: 973 year: 2009 ident: 9886_CR59 publication-title: Nat Cell Biol doi: 10.1038/ncb1909 – volume: 17 start-page: 163 year: 2017 ident: 9886_CR53 publication-title: BMC Cardiovasc Disord doi: 10.1186/s12872-017-0596-0 – volume: 41 start-page: 2 year: 2019 ident: 9886_CR8 publication-title: Genes Environ doi: 10.1186/s41021-019-0119-6 – volume: 7 start-page: 5120 year: 2017 ident: 9886_CR40 publication-title: Sci Rep doi: 10.1038/s41598-017-03434-0 – ident: 9886_CR13 doi: 10.1371/journal.pone.0074466 – ident: 9886_CR6 doi: 10.1016/j.yjmcc.2015.07.005 – volume: 10 start-page: 463 year: 2019 ident: 9886_CR20 publication-title: Front Pharmacol doi: 10.3389/fphar.2019.00463 – volume: 107 start-page: 11948 issue: 26 year: 2010 ident: 9886_CR14 publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.0914143107 – volume: 17 start-page: 217 year: 2013 ident: 9886_CR56 publication-title: Expert Opin Ther Targets doi: 10.1517/14728222.2013.745512 – volume: 10 start-page: 123 year: 2019 ident: 9886_CR57 publication-title: Front Physiol doi: 10.3389/fphys.2019.00123 – volume: 107 start-page: 677 year: 2010 ident: 9886_CR27 publication-title: Circ Res doi: 10.1161/CIRCRESAHA – volume: 13 start-page: 16929 year: 2012 ident: 9886_CR4 publication-title: Int J Mol Sci doi: 10.3390/ijms131216929 – volume: 8 start-page: 2199 year: 2019 ident: 9886_CR29 publication-title: J Clin Med doi: 10.3390/jcm8122199 – volume: 2 start-page: 519 year: 2013 ident: 9886_CR25 publication-title: Ann Cardiothorac Surg doi: 10.3978/j.issn.2225-319X.2013.07.06 – volume: 46 start-page: 100421 year: 2021 ident: 9886_CR39 publication-title: Curr Probl Cardiol doi: 10.1016/j.cpcardiol.2019.04.001 – volume: 111 start-page: 32 year: 2023 ident: 9886_CR55 publication-title: Clin Biochem doi: 10.1016/j.clinbiochem.2022 – volume: 146 start-page: 949 year: 2013 ident: 9886_CR37 publication-title: J Thorac Cardiovasc Surg doi: 10.1016/j.jtcvs.2012.12.064 – volume: 26 start-page: 43 year: 2020 ident: 9886_CR9 publication-title: Hum Reprod Update doi: 10.1093/humupd/dmz043 – volume: 6 start-page: 21789 year: 2016 ident: 9886_CR31 publication-title: Sci Rep doi: 10.1038/srep21789 – volume: 116 start-page: 816 year: 2015 ident: 9886_CR3 publication-title: Circ Res doi: 10.1161/CIRCRESAHA – volume: 11 start-page: 1509 year: 2022 ident: 9886_CR16 publication-title: Cells doi: 10.3390/cells11091509 – volume: 17 start-page: 1275 year: 2011 ident: 9886_CR23 publication-title: Nat Med doi: 10.1038/nm.2459 – volume: 107 start-page: 6982 year: 2010 ident: 9886_CR22 publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.1002472107 – volume: 9 start-page: 1040971 year: 2022 ident: 9886_CR10 publication-title: Front Cardiovasc Med doi: 10.3389/fcvm.2022.1040971 – volume: 101 start-page: 723 year: 2007 ident: 9886_CR42 publication-title: Circ Res doi: 10.1161/CIRCRESAHA.107.152942 – volume: 27 start-page: 290 year: 2023 ident: 9886_CR58 publication-title: Genet Test Mol Biomarkers doi: 10.1089/gtmb.2023.0002 – volume: 29 start-page: 869 year: 2016 ident: 9886_CR62 publication-title: Pak J Pharm Sci |
| SSID | ssj0004175 |
| Score | 2.3842251 |
| Snippet | Background
Atherosclerosis, serving as the primary pathological mechanism at the core of cardiovascular disease, is now widely acknowledged to be associated... Atherosclerosis, serving as the primary pathological mechanism at the core of cardiovascular disease, is now widely acknowledged to be associated with DNA... BackgroundAtherosclerosis, serving as the primary pathological mechanism at the core of cardiovascular disease, is now widely acknowledged to be associated... BACKGROUND: Atherosclerosis, serving as the primary pathological mechanism at the core of cardiovascular disease, is now widely acknowledged to be associated... |
| SourceID | proquest pubmed crossref springer |
| SourceType | Aggregation Database Index Database Publisher |
| StartPage | 953 |
| SubjectTerms | 8-Hydroxy-2'-Deoxyguanosine - metabolism 8-Hydroxydeoxyguanosine Aged Animal Anatomy Animal Biochemistry Arteriosclerosis Atherosclerosis Atherosclerosis - genetics Atherosclerosis - metabolism biomarkers Biomedical and Life Sciences blood serum BRCA1 protein Cardiovascular disease Cardiovascular diseases Carotid arteries Carotid Arteries - metabolism Carotid Arteries - pathology Carotid artery Carotid Artery Diseases - genetics Carotid Artery Diseases - metabolism Chromosome 3 Chromosome 5 Coronary artery disease Coronary Artery Disease - genetics Coronary Artery Disease - metabolism Coronary vessels Cross-Sectional Studies Deoxyguanosine DNA damage DNA Damage - genetics DNA repair DNA Repair - genetics Female Gene expression Gene Expression Regulation - genetics genes Heart diseases Histology Humans Life Sciences Male MicroRNAs - genetics MicroRNAs - metabolism Middle Aged miRNA Morphology Original Article Plaque, Atherosclerotic - genetics Plaque, Atherosclerotic - metabolism Plaques Polymerase chain reaction quantitative polymerase chain reaction Therapeutic targets therapeutics tumor suppressor proteins Vein & artery diseases |
| Title | A cross-sectional study comparing the expression of DNA repair molecules in subjects with and without atherosclerotic plaques |
| URI | https://link.springer.com/article/10.1007/s11033-024-09886-8 https://www.ncbi.nlm.nih.gov/pubmed/39230767 https://www.proquest.com/docview/3100714339 https://www.proquest.com/docview/3100565042 https://www.proquest.com/docview/3153773002 |
| Volume | 51 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3da9swED-6lrK-jC7d2mxp0GBvrSC2LFl6NF3SsLI-LZA9GcWSILDaIU5ge9j_vpNsJ4xsg74ZfD6fdbLuJ90XwEc7ShJtVUyF04wmYmTxnys4TbWTVkZMq5Au9uVRTGfJ5zmft0lhdRft3rkkw0q9T3aLfN8xtCl0pKQUVL6AE-737jiLZ3G2z4aMQnldj_VpgoCiTZX5O48_zdEBxjzwjwazMzmHVy1eJFmj4NdwZMsenDYdJH_24OVd17DtAn5lJLyE1iG8yj8WiseSJs4c2RNEe8T-aGNfS1I58ukxI2s0Scs1eWo65dqaLEtSbxf-hKYm_qCW6NKEi2q7IQEyVjVKs65QKLL6rv3XvIHZZPz1bkrb7gq0YFxtcAeK0EMLl4p0gRhOs8iwRC6Ur-euklijqowykRNCO7RvlpmCa8Vl6orUxQVjb-G4rEp7BYRbZIRQEfkgQHC4bhmjPHiTRiTcmj7cdIOcr5oiGvm-XLJXSY4qyYNKctmHQaeHvP2h6tz7IXyrdqb68GF3GwfY-zd0aattQ4P4FJeh_9Fwlvoa_Uhz2eh4JxJCRVzxRNqH207pewH-Le-755G_h7PYT8AQEjOA4816a68R2GwWQzjJ7r89jIdhPv8Gfn3vxg |
| linkProvider | Springer Nature |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1LS8QwEB58IHoR367PCN40sG3aNDkuPlhfe3LBW8k2CQjaynYX9OB_d5K2u8iq4K3Q6XSaSTJfMy-AU9OOImVkSLlVjEa8bXDNZTFNlBVGBExJny720OPdfnT7FD_VSWFlE-3euCT9Tj1Ndgtc3zG0KbQtheBUzMMiggHhArn6YWeaDRn48roO69MIAUWdKvMzj-_maAZjzvhHvdm5XoPVGi-STqXgdZgz-QYsVR0kPzZg-aJp2LYJnx3iX0JLH17lHvPFY0kVZ47sCaI9Yt7r2NecFJZc9jpkiCbpeUheq065piTPOSnHA3dCUxJ3UEtUrv1FMR4RDxmLEqUZFigUeXtR7mu2oH999XjRpXV3BZqxWI7wDxShh-I24ckAMZxigWaRGEhXz11GoUJVaakDy7myaN8M01msZCwSmyU2zBjbhoW8yM0ukNggI4SKyAcBgsV9S2vpwJvQPIqNbsFZM8jpW1VEI52WS3YqSVElqVdJKlpw0OghrRdUmTo_hGvVzmQLTia3cYCdf0PlphhXNIhPcRv6iyZmiavRjzQ7lY4nIiFUxB2PJy04b5Q-FeB3eff-R34My93Hh_v0_qZ3tw8roZuMPjzmABZGw7E5RJAzGhz5Of0Fa6nxJQ |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3da9swED-6lK57GWv20Wxdq0LfNtHYsmXpMSQL6VfoQwN5M4olQWCzQ-zA9rD_fSfZbjqyDfZm8Pl81km6n3VfABemH0XKyJByqxiNeN_gmstimigrjAiYkj5d7G7KJ7Poeh7Pn2Tx-2j31iVZ5zS4Kk15dbnS9nKb-Ba4HmRoX2hfCsGpeAb7uB0Hbl7PwsE2MzLwpXYd7qcRgosmbebPPH43TTt4c8dX6k3Q-BW8bLAjGdTKPoI9k3fhoO4m-aMLh8O2edtr-Dkg_iW09KFW7jFfSJbUMefIniDyI-Z7Ewebk8KS0XRA1mielmvyre6aa0qyzEm5WbjTmpK4Q1uicu0vik1FPHwsSpRmXaBQZPVVua95A7Pxl4fhhDadFmjGYlnh3yjCEMVtwpMF4jnFAs0isZCutruMQoVq01IHlnNl0dYZprNYyVgkNktsmDH2Fjp5kZtjILFBRggbkQ-CBYt7mNbSATmheRQb3YNP7SCnq7qgRrotnexUkqJKUq-SVPTgpNVD2iyuMnU-Cde2nckenD_exgF2vg6Vm2JT0yBWxS3pXzQxS1y9fqR5V-v4USSEjbj78aQHn1ulbwX4u7zv_4_8DJ7fj8bp7dX05gO8CN1c9JEyJ9Cp1hvzEfFOtTj1U_oXU2n1YQ |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+cross-sectional+study+comparing+the+expression+of+DNA+repair+molecules+in+subjects+with+and+without+atherosclerotic+plaques&rft.jtitle=Molecular+biology+reports&rft.au=Arapi%2C+Berk&rft.au=Unal%2C+Selin&rft.au=Malikova%2C+Narmina&rft.au=Omeroglu%2C+Suat+Nail&rft.date=2024-12-01&rft.eissn=1573-4978&rft.volume=51&rft.issue=1&rft.spage=953&rft_id=info:doi/10.1007%2Fs11033-024-09886-8&rft_id=info%3Apmid%2F39230767&rft.externalDocID=39230767 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0301-4851&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0301-4851&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0301-4851&client=summon |